Trelagliptin CAS 865759-25-7
Trelagliptin CAS 865759-25-7

Trelagliptin CAS 865759-25-7

Trelagliptin, also known as SYR-472, is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed by Takeda for the treatment of type 2 diabetes (T2D). Once-weekly SYR-472 treatment produced clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes. It was well tolerated and might be a new treatment option for patients with this disease. Trelagliptin (Zafatek(®)) was approved in Japan for the treatment of type 2 diabetes mellitus (T2DM).
Send Inquiry

Product Description 

Trelagliptin

Trelagliptin, also known as SYR-472, is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed by Takeda for the treatment of type 2 diabetes (T2D). Once-weekly SYR-472 treatment produced clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes. It was well tolerated and might be a new treatment option for patients with this disease. Trelagliptin (Zafatek(®)) was approved in Japan for the treatment of type 2 diabetes mellitus (T2DM). 
Specifications

Product Name Trelagliptin
CAS NO. 865759-25-7
MOQ 1 kg
Other Name Trelagliptin (USAN),Trelagliptin,UNII-Q836OWG55H,SYR 472
Molecular Formular C18H20FN5O2
Molecular Weight 357.382
Appearance White powder
Brand Monad
Purity 0.99
Density 1.4±0.1 g/cm3
LogP 1.88
Boiling Point 519.0±60.0 °C at 760 mmHg
Flash Point 267.7±32.9 °C

 

Hot Tags: trelagliptin cas 865759-25-7, China, manufacturers, suppliers, factory, cheap, discount, quotation, low price, free sample